FdaApplication

NDA 209449

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCYCLE PHARMACEUTICALS LTD
application_typeNDA
approval_date2017-07-26

Products (4)

ProductActive ingredientStrengthDosage form
HARLIKUNITISINONE2MGTABLET;ORAL
NITYRNITISINONE5MGTABLET;ORAL
NITYRNITISINONE2MGTABLET;ORAL
NITYRNITISINONE10MGTABLET;ORAL

4 products